Adma Biologics | ADMA - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2027Q1 Mar/2026 0.19 0.12 May/13




Eps Alterar Data
Adma Biologics USD 0.2 0.05 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Novavax USD 0.13 0.59 2025-12
Omeros USD -1.12 0.37 2024-06
Takeda JPY 65.74 73.57 2025-12